These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3095774)

  • 1. [Bacteriostatic activity of azlocillin, gentamycin, amikacin singly or in combination on 200 strains of Pseudomonas aeruginosa].
    Texier-Maugein J; Fourche J; Mormede M; Mazaud C; Bébéar C
    Pathol Biol (Paris); 1986 May; 34(5):415-8. PubMed ID: 3095774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
    Petit JC; Richard G; Burghoffer B; Daguet GL
    Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic activity of amikacin with aztreonam against Pseudomonas aeruginosa and other gram-negative organisms.
    Greenberg RN; Bollinger M; Compton J
    Clin Ther; 1986; 8(3):354-8. PubMed ID: 3087621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods.
    Moody JA; Gerding DN; Peterson LR
    Am J Med; 1987 Apr; 82(4A):44-54. PubMed ID: 3107380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro synergistic effect of ciprofloxacin with aminoglycosides against multidrug resistant-Pseudomonas aeruginosa.
    Yasmin F; Akhtar N; Hameed A
    Pak J Pharm Sci; 2013 Sep; 26(5):1041-4. PubMed ID: 24035966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of methods for assessing in vitro antibiotic synergism against Pseudomonas and Serratia.
    Weinstein RJ; Young LS; Hewitt WL
    J Lab Clin Med; 1975 Nov; 86(5):853-62. PubMed ID: 810533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Susceptibility of Pseudomonas aeruginosa to aztreonam in comparison to other pseudomonas-active beta-lactam antibiotics and gentamicin].
    Wundt W; Lange KP; Baumgärtner M
    Arzneimittelforschung; 1985; 35(8):1322-5. PubMed ID: 3935123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of antimicrobial combinations in vitro: the relativity of synergism.
    Blaser J
    Scand J Infect Dis Suppl; 1990; 74():71-9. PubMed ID: 2129067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single daily dosing of amikacin in an in-vitro model.
    Dudley MN; Zinner SH
    J Antimicrob Chemother; 1991 May; 27 Suppl C():15-9. PubMed ID: 1906862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of in vitro antibacterial activity of 19 antimicrobial agents against Pseudomonas aeruginosa.
    Wang R; Sun XD; Cai QM
    Chin Med J (Engl); 1989 Apr; 102(4):313-8. PubMed ID: 2507247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined in vitro effect of new betalactam antibiotics and aminoglycosides against Pseudomonas aeruginosa ].
    Thabaut A; Durosoir JL; Meyran M
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):549-54. PubMed ID: 6812006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Susceptibility of Pseudomonas aeruginosa to aminoglycosides: effect of free calcium and magnesium].
    Christe M; Vaudaux P; Waldvogel FA
    Schweiz Med Wochenschr; 1982 Feb; 112(7):234-41. PubMed ID: 6803358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin.
    Drago L; De Vecchi E; Nicola L; Tocalli L; Gismondo MR
    J Antimicrob Chemother; 2005 Aug; 56(2):353-9. PubMed ID: 15967767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity and synergy of ureido penicillins and aminoglycosides against Pseudomonas aeruginosa.
    Hoogkamp-Korstanje JA; Westerdaal NA
    Infection; 1982; 10 Suppl 3():S257-61. PubMed ID: 6818158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of ceftriaxone alone and in combination with gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.
    Watanakunakorn C
    Antimicrob Agents Chemother; 1983 Aug; 24(2):305-6. PubMed ID: 6314890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefoxitin: synergism with aminoglycosides in vitro.
    Une T; Osada Y; Ogawa H
    Arzneimittelforschung; 1981; 31(5):761-4. PubMed ID: 6791664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
    Johnson DE; Thompson B
    Am J Med; 1986 May; 80(5C):53-8. PubMed ID: 3636060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciprofloxacin, azlocillin, ceftizoxime and amikacin alone and in combination against gram-negative bacilli in an infected chamber model.
    Bamberger DM; Peterson LR; Gerding DN; Moody JA; Fasching CE
    J Antimicrob Chemother; 1986 Jul; 18(1):51-63. PubMed ID: 3093445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activities of ureidopenicillins alone and in combination with amikacin and three cephalosporin antibiotics.
    Moody JA; Peterson LR; Gerding DN
    Antimicrob Agents Chemother; 1984 Aug; 26(2):256-9. PubMed ID: 6435516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.